Stool test (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Stool test" in English language version.

refsWebsite

Global rank English rank

10nih.gov

4^th place

6doi.org

2^nd place

2webmd.com

1,169^th place

1,075^th place

1medilib.ir

low place

1semanticscholar.org

11^th place

8^th place

1web.archive.org

1^st place

1cancer.org

3,680^th place

2,918^th place

1ncqa.org

low place

1fda.gov

447^th place

338^th place

1clinical-colorectal-cancer.com

low place

1medicinenet.com

3,840^th place

3,358^th place

cancer.org

"American Cancer Society recommendations for colorectal cancer early detection". www.cancer.org. Archived from the original on 3 December 2016. Retrieved 14 July 2016.

clinical-colorectal-cancer.com

Berger BM, Shroy PC, Dinh TA (2015). "Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness". Clinical Colorectal Cancer. 15 (3): e65–e74. doi:10.1016/j.clcc.2015.12.003. PMID 26792032.

doi.org

Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM (March 2009). "American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]". The American Journal of Gastroenterology. 104 (3): 739–750. doi:10.1038/ajg.2009.104. PMID 19240699. S2CID 295873.
Osborn NK, Ahlquist DA (2005). "Stool screening for colorectal cancer: molecular approaches". Gastroenterology. 128 (1): 192–206. doi:10.1053/j.gastro.2004.10.041. PMID 15633136.
Tepus M, Yau TO (20 May 2020). "Non-Invasive Colorectal Cancer Screening: An Overview". Gastrointestinal Tumors. 7 (3): 62–73. doi:10.1159/000507701. PMC 7445682. PMID 32903904.
Barzi A, Lenz HJ, Quinn DI, Sadeghi S (1 May 2017). "Comparative effectiveness of screening strategies for colorectal cancer". Cancer. 123 (9): 1516–1527. doi:10.1002/cncr.30518. PMC 6879196. PMID 28117881.
Berger BM, Shroy PC, Dinh TA (2015). "Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness". Clinical Colorectal Cancer. 15 (3): e65–e74. doi:10.1016/j.clcc.2015.12.003. PMID 26792032.
Mommersteeg MC, Nieuwenburg SA, Wolters LM, Roovers BH, van Vuuren HA, Verhaar AP, Bruno MJ, Kuipers EJ, Peppelenbosch MP, Spaander MC, Fuhler GM (November 2023). "The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance". United European Gastroenterol J. 11 (9): e894-903. doi:10.1002/ueg2.12473. PMC 10637120. PMID 37854002.

fda.gov

"FDA approves first non-invasive DNA screening test for colorectal cancer [press release]". Food and Drug Administration. August 11, 2014. Retrieved 30 June 2015.

medicinenet.com

"Stool Acidity Test - MedicineNet.com".

medilib.ir

"Approach to stool microscopy". medilib (in Persian). 2021-06-02. Retrieved 2022-08-16.

ncqa.org

National Committee for Quality Assurance. "Healthcare Effectiveness Data and Information Set 2017 Volume 2: Technical Update" (PDF).

nih.gov

pubmed.ncbi.nlm.nih.gov

Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM (March 2009). "American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]". The American Journal of Gastroenterology. 104 (3): 739–750. doi:10.1038/ajg.2009.104. PMID 19240699. S2CID 295873.
Osborn NK, Ahlquist DA (2005). "Stool screening for colorectal cancer: molecular approaches". Gastroenterology. 128 (1): 192–206. doi:10.1053/j.gastro.2004.10.041. PMID 15633136.
Tepus M, Yau TO (20 May 2020). "Non-Invasive Colorectal Cancer Screening: An Overview". Gastrointestinal Tumors. 7 (3): 62–73. doi:10.1159/000507701. PMC 7445682. PMID 32903904.
Barzi A, Lenz HJ, Quinn DI, Sadeghi S (1 May 2017). "Comparative effectiveness of screening strategies for colorectal cancer". Cancer. 123 (9): 1516–1527. doi:10.1002/cncr.30518. PMC 6879196. PMID 28117881.
Berger BM, Shroy PC, Dinh TA (2015). "Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness". Clinical Colorectal Cancer. 15 (3): e65–e74. doi:10.1016/j.clcc.2015.12.003. PMID 26792032.
Mommersteeg MC, Nieuwenburg SA, Wolters LM, Roovers BH, van Vuuren HA, Verhaar AP, Bruno MJ, Kuipers EJ, Peppelenbosch MP, Spaander MC, Fuhler GM (November 2023). "The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance". United European Gastroenterol J. 11 (9): e894-903. doi:10.1002/ueg2.12473. PMC 10637120. PMID 37854002.

ncbi.nlm.nih.gov

Tepus M, Yau TO (20 May 2020). "Non-Invasive Colorectal Cancer Screening: An Overview". Gastrointestinal Tumors. 7 (3): 62–73. doi:10.1159/000507701. PMC 7445682. PMID 32903904.
Barzi A, Lenz HJ, Quinn DI, Sadeghi S (1 May 2017). "Comparative effectiveness of screening strategies for colorectal cancer". Cancer. 123 (9): 1516–1527. doi:10.1002/cncr.30518. PMC 6879196. PMID 28117881.
Mommersteeg MC, Nieuwenburg SA, Wolters LM, Roovers BH, van Vuuren HA, Verhaar AP, Bruno MJ, Kuipers EJ, Peppelenbosch MP, Spaander MC, Fuhler GM (November 2023). "The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance". United European Gastroenterol J. 11 (9): e894-903. doi:10.1002/ueg2.12473. PMC 10637120. PMID 37854002.

nlm.nih.gov

"MedlinePlus Medical Encyclopedia: Fecal fat".

semanticscholar.org

api.semanticscholar.org

Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM (March 2009). "American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]". The American Journal of Gastroenterology. 104 (3): 739–750. doi:10.1038/ajg.2009.104. PMID 19240699. S2CID 295873.

web.archive.org

"American Cancer Society recommendations for colorectal cancer early detection". www.cancer.org. Archived from the original on 3 December 2016. Retrieved 14 July 2016.